Empowering Voices in Core Outcome Set Development in Rheumatology
OMERACT 2027 PRP APPLICATION
This application process is designed to select Patient Research Partners (PRPs) for in-person attendance at the OMERACT 2027 conference. OMERACT 2027 is scheduled to take place May 19-23, 2027, in Toronto, Canada. https://omeract.org/om2027/. It aims to ensure equitable access for PRPs from diverse backgrounds, disease representations, and geographic locations, fostering transparency and accountability in the selection process. Please include in your application letter as many of these criteria that pertain to your experience as a PRP.
Eligibility Criteria for OMERACT 2027 In-Person Attendance
We welcome a diverse range of applicants for participation, recognizing that prospective PRPs may vary from seasoned OMERACT veterans to those newly embarking on their journey.
Letter of support
A letter of support is required as part of the OMERACT 2027 Patient Research Partner (PRP) application. Letters help the review committee understand your engagement with OMERACT, your contributions, and your readiness to participate in an in-person conference.
Letters are typically provided by an OMERACT Working Group Co-Chair relevant external organization may provide a letter if you are not yet affiliated with an OMERACT Working Group.
Letters may be uploaded within the application or emailed to admin@omeract.org by March 31, 2026.
Expectations and Commitments for PRPs Attending an In-Person OMERACT Conference:
PRPs selected to attend OMERACT 2027 are expected to actively participate before, during, and after the conference. This includes engagement in conference sessions, completion of pre-conference preparation, collaborative participation with researchers and fellow PRPs, and post-conference feedback and knowledge sharing.
Applicants will be asked to review and confirm their understanding of the full Expectations and Commitments as part of the online application process.
OMERACT 2027 PRP APPLICATION Q&A
Date: Tuesday February 17, 2026
Time: 2:30–3:30 PM (America/Toronto) Find your local time
Join us for an informal Q&A session for individuals interested in applying as a Patient Research Partner (PRP) for the OMERACT 2027 in-person conference.
During this session, members of the OMERACT team will:
- Walk through the PRP application process
- Explain what the review committee looks for in a strong application
- Clarify eligibility, expectations, and letters of support
- Answer questions from prospective applicants
This session is optional but strongly encouraged, particularly for first-time applicants or those new to OMERACT.
Selection Process:
- The application review and scoring will be conducted by a specialized committee, including the Chair of the OMERACT PRP Support Team and selected representatives from OMERACT.
- Candidates will be chosen based on how well they meet the established criteria and the anticipated positive impact of their involvement in the program.
Please note that the online application was designed to be completed on a computer. Some users have experienced issues when submitting the form on a phone or tablet.
OMERACT 2027 PRP APPLICATION Frequently asked questions
We strongly encourage all applicants to review the OMERACT 2027 PRP Application FAQ before completing the application.
The FAQ provides detailed information on:
- Eligibility and selection criteria
- Letters of support
- Funding, travel, and reimbursement
- Expectations and commitments for PRPs
- Accessibility, preparation, and support
- What to expect before, during, and after the conference
Reviewing the FAQ in advance will help you understand the application process, prepare your responses, and determine whether this opportunity is the right fit for you.
This website uses cookies.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.